| Ipca Laboratories Ltd | 39,474 Cr. | 1,556 | 1,624/1,252 | 37.4 | 293 | 0.26 % | 14.7 % | 12.8 % | 1.00 |
| Glaxosmithkline Pharmaceuticals Ltd | 41,877 Cr. | 2,472 | 3,516/2,218 | 41.6 | 101 | 1.70 % | 63.2 % | 46.9 % | 10.0 |
| Ajanta Pharma Ltd | 34,548 Cr. | 2,765 | 3,228/2,330 | 34.0 | 345 | 1.01 % | 32.4 % | 24.9 % | 2.00 |
| J B Chemicals & Pharmaceuticals Ltd | 32,205 Cr. | 2,006 | 2,195/1,495 | 42.7 | 243 | 0.77 % | 25.8 % | 20.1 % | 1.00 |
| Gland Pharma Ltd | 28,231 Cr. | 1,714 | 2,131/1,382 | 23.8 | 610 | 1.05 % | 15.8 % | 11.6 % | 1.00 |
| Abbott India Ltd | 53,508 Cr. | 25,180 | 37,000/25,150 | 35.1 | 1,888 | 1.89 % | 46.2 % | 35.7 % | 10.0 |
| Wockhardt Ltd | 22,833 Cr. | 1,405 | 1,870/1,087 | 210 | 281 | 0.00 % | 3.75 % | 1.22 % | 5.00 |
| Biocon Ltd | 56,707 Cr. | 350 | 425/313 | 69.1 | 200 | 0.14 % | 6.25 % | 4.76 % | 5.00 |
| Pfizer Ltd | 21,653 Cr. | 4,733 | 5,993/4,100 | 28.4 | 841 | 0.74 % | 21.6 % | 16.4 % | 10.0 |
| Astrazeneca Pharma India Ltd | 21,250 Cr. | 8,500 | 10,691/7,552 | 102 | 320 | 0.38 % | 33.4 % | 23.6 % | 2.00 |
| Acutaas Chemicals Ltd | 19,608 Cr. | 2,395 | 2,688/1,040 | 68.3 | 173 | 0.06 % | 19.9 % | 16.0 % | 5.00 |
| Natco Pharma Ltd | 19,580 Cr. | 1,093 | 1,135/752 | 12.6 | 483 | 0.55 % | 32.8 % | 28.0 % | 2.00 |
| ERIS Lifesciences Ltd | 19,029 Cr. | 1,374 | 1,910/1,236 | 42.9 | 227 | 0.54 % | 12.2 % | 12.9 % | 1.00 |
| Laurus Labs Ltd | 60,110 Cr. | 1,113 | 1,145/572 | 75.1 | 91.1 | 0.11 % | 9.47 % | 7.75 % | 2.00 |
| Neuland Laboratories Ltd | 18,481 Cr. | 14,405 | 19,748/10,578 | 103 | 1,263 | 0.08 % | 18.7 % | 14.8 % | 10.0 |
| Granules India Ltd | 17,084 Cr. | 689 | 696/431 | 31.4 | 164 | 0.22 % | 15.1 % | 13.9 % | 1.00 |
| Alkem Laboratories Ltd | 62,592 Cr. | 5,235 | 5,934/4,716 | 26.1 | 1,116 | 0.86 % | 20.4 % | 19.4 % | 2.00 |
| Jubilant Pharmova Ltd | 15,060 Cr. | 945 | 1,250/784 | 32.6 | 414 | 0.53 % | 9.54 % | 9.55 % | 1.00 |
| Alembic Pharmaceuticals Ltd | 14,763 Cr. | 751 | 1,108/635 | 22.2 | 271 | 1.46 % | 13.0 % | 11.4 % | 2.00 |
| Glenmark Life Sciences Ltd | 64,892 Cr. | 2,300 | 2,373/1,340 | 24.0 | 340 | 0.11 % | 19.4 % | 15.8 % | 1.00 |
| Glenmark Pharmaceuticals Ltd | 64,892 Cr. | 2,300 | 2,373/1,340 | 24.0 | 340 | 0.11 % | 19.4 % | 15.8 % | 1.00 |
| Cohance Lifesciences Ltd | 13,776 Cr. | 360 | 1,190/267 | 45.8 | 99.0 | 0.00 % | 14.9 % | 12.7 % | 1.00 |
| Caplin Point Laboratories Ltd | 13,070 Cr. | 1,720 | 2,397/1,500 | 21.3 | 416 | 0.35 % | 25.8 % | 22.7 % | 2.00 |
| Concord Biotech Ltd | 10,631 Cr. | 1,016 | 2,150/987 | 33.5 | 174 | 1.05 % | 28.4 % | 21.4 % | 1.00 |
| Sequent Scientific Ltd | 8,768 Cr. | 201 | 260/111 | 203 | 32.2 | 0.00 % | 8.47 % | 3.21 % | 2.00 |
| Marksans Pharma Ltd | 8,620 Cr. | 190 | 271/155 | 23.9 | 59.3 | 0.42 % | 20.0 % | 16.8 % | 1.00 |
| Procter & Gamble Health Ltd | 8,530 Cr. | 5,139 | 6,739/4,700 | 29.1 | 373 | 2.43 % | 47.8 % | 36.4 % | 10.0 |
| Shilpa Medicare Ltd | 8,095 Cr. | 414 | 502/260 | 45.8 | 125 | 0.12 % | 7.82 % | 4.21 % | 1.00 |
| Sanofi India Ltd | 7,894 Cr. | 3,428 | 6,410/3,151 | 22.8 | 326 | 2.19 % | 57.5 % | 43.0 % | 10.0 |
| Blue Jet Healthcare Ltd | 6,997 Cr. | 403 | 1,028/325 | 23.8 | 72.4 | 0.30 % | 39.8 % | 30.2 % | 2.00 |
| Aarti Pharmalabs Ltd | 6,282 Cr. | 693 | 972/584 | 29.1 | 226 | 0.72 % | 17.4 % | 14.5 % | 5.00 |
| FDC Ltd | 5,961 Cr. | 366 | 528/313 | 25.7 | 149 | 1.37 % | 15.9 % | 11.8 % | 1.00 |
| Entero Healthcare Solutions Ltd | 5,439 Cr. | 1,250 | 1,511/944 | 46.7 | 406 | 0.00 % | 8.71 % | 5.63 % | 10.0 |
| Suven Life Sciences Ltd | 5,328 Cr. | 202 | 303/120 | | 12.4 | 0.00 % | 87.0 % | 87.2 % | 1.00 |
| Zota Health Care Ltd | 4,475 Cr. | 1,292 | 1,740/802 | | 93.5 | 0.08 % | 17.0 % | 36.0 % | 10.0 |
| Gujarat Themis Biosyn Ltd | 3,922 Cr. | 360 | 479/225 | 82.1 | 24.3 | 0.19 % | 27.3 % | 21.7 % | 1.00 |
| SMS Pharmaceuticals Ltd | 3,715 Cr. | 397 | 448/205 | 42.6 | 81.2 | 0.10 % | 12.2 % | 11.0 % | 1.00 |
| RPG Life Sciences Ltd | 3,363 Cr. | 2,033 | 2,725/1,731 | 32.0 | 335 | 0.98 % | 32.8 % | 25.5 % | 8.00 |
| Advanced Enzyme Technologies Ltd | 3,347 Cr. | 299 | 367/252 | 23.2 | 133 | 1.74 % | 13.1 % | 9.54 % | 2.00 |
| Aarti Drugs Limited | 3,347 Cr. | 367 | 575/319 | 18.0 | 147 | 0.55 % | 13.5 % | 13.0 % | 10.0 |
| Gufic BioSciences Ltd | 2,991 Cr. | 298 | 409/268 | 59.2 | 62.7 | 0.03 % | 13.2 % | 12.3 % | 1.00 |
| Orchid Pharma Ltd | 2,875 Cr. | 567 | 899/471 | 111 | 251 | 0.00 % | 8.07 % | 8.21 % | 10.0 |
| Bliss GVS Pharma Ltd | 2,779 Cr. | 263 | 278/105 | 25.1 | 107 | 0.19 % | 11.7 % | 8.36 % | 1.00 |
| Dishman Carbogen Amcis Ltd | 2,650 Cr. | 169 | 322/128 | 20.1 | 406 | 0.00 % | 2.42 % | 0.32 % | 2.00 |
| Unichem Laboratories Ltd | 2,622 Cr. | 372 | 668/278 | 24.9 | 346 | 0.00 % | 6.24 % | 5.59 % | 2.00 |
| IOL Chemicals & Pharmaceuticals Ltd | 2,616 Cr. | 89.1 | 127/60.6 | 21.0 | 59.7 | 1.12 % | 8.86 % | 6.13 % | 2.00 |
| Morepen Laboratories Ltd | 2,286 Cr. | 41.7 | 70.5/33.0 | 29.9 | 21.8 | 0.48 % | 15.1 % | 11.8 % | 2.00 |
| Panacea Biotec Ltd | 2,257 Cr. | 369 | 582/292 | | 135 | 0.00 % | 4.57 % | 4.92 % | 1.00 |
| Hikal Ltd | 2,233 Cr. | 181 | 449/146 | 89.3 | 96.9 | 0.77 % | 9.85 % | 7.38 % | 2.00 |
| Indoco Remedies Ltd | 1,905 Cr. | 206 | 350/162 | | 106 | 0.10 % | 0.49 % | 7.02 % | 2.00 |
| Solara Active Pharma Sciences Ltd | 1,727 Cr. | 478 | 734/422 | | 347 | 0.00 % | 6.01 % | 0.05 % | 10.0 |
| Kwality Pharmaceuticals Ltd | 1,682 Cr. | 1,622 | 1,782/666 | 29.4 | 281 | 0.00 % | 18.2 % | 16.2 % | 10.0 |
| Amrutanjan Health Care Ltd | 1,667 Cr. | 577 | 791/486 | 28.8 | 118 | 0.80 % | 22.4 % | 16.5 % | 1.00 |
| Beta Drugs Ltd | 1,354 Cr. | 1,336 | 2,000/990 | 31.4 | 219 | 0.00 % | 27.0 % | 25.9 % | 10.0 |
| Jagsonpal Pharmaceuticals Ltd | 1,337 Cr. | 199 | 302/155 | 31.4 | 37.9 | 1.26 % | 23.0 % | 18.6 % | 2.00 |
| TTK Healthcare Ltd | 1,301 Cr. | 920 | 1,402/735 | 18.7 | 768 | 1.09 % | 9.26 % | 6.89 % | 10.0 |
| Hester Biosciences Ltd | 1,269 Cr. | 1,492 | 2,350/1,239 | 31.0 | 397 | 0.47 % | 9.71 % | 9.18 % | 10.0 |
| Venus Remedies Ltd | 1,269 Cr. | 950 | 1,119/294 | 16.6 | 445 | 0.00 % | 11.1 % | 7.16 % | 10.0 |
| Syncom Formulations (India) Ltd | 1,266 Cr. | 13.5 | 23.5/10.2 | 18.4 | 4.00 | 0.00 % | 18.6 % | 15.5 % | 1.00 |
| Lincoln Pharmaceuticals Ltd | 1,213 Cr. | 606 | 679/440 | 13.8 | 357 | 0.30 % | 17.3 % | 12.8 % | 10.0 |
| Ind-Swift Laboratories Ltd | 1,193 Cr. | 137 | 157/67.2 | 25.2 | 160 | 0.00 % | 0.78 % | 0.18 % | 10.0 |
| Fredun Pharmaceuticals Ltd | 1,165 Cr. | 2,113 | 2,170/655 | 34.2 | 294 | 0.03 % | 18.9 % | 15.8 % | 10.0 |
| Fermenta Biotech Ltd | 937 Cr. | 318 | 399/252 | 10.6 | 133 | 0.79 % | 23.0 % | 24.9 % | 5.00 |
| Wanbury Ltd | 902 Cr. | 258 | 330/162 | 21.0 | 18.1 | 0.00 % | 36.7 % | 76.5 % | 10.0 |
| Themis Medicare Ltd | 888 Cr. | 96.4 | 179/65.0 | | 41.3 | 0.52 % | 10.4 % | 7.65 % | 1.00 |
| Anuh Pharma Ltd | 813 Cr. | 81.1 | 115/66.7 | 19.4 | 32.6 | 1.85 % | 17.2 % | 13.4 % | 5.00 |
| Kopran Ltd | 750 Cr. | 155 | 213/107 | 45.3 | 104 | 1.93 % | 9.75 % | 7.64 % | 10.0 |
| Kilitch Drugs (India) Ltd | 532 Cr. | 152 | 250/117 | 20.4 | 75.9 | 0.00 % | 15.7 % | 12.6 % | 10.0 |
| Albert David Ltd | 398 Cr. | 697 | 959/580 | 41.4 | 690 | 0.72 % | 6.45 % | 4.39 % | 10.0 |
| SMS Lifesciences India Ltd | 357 Cr. | 1,197 | 1,680/956 | 20.6 | 650 | 0.13 % | 11.8 % | 10.8 % | 10.0 |
| Bafna Pharmaceuticals Ltd | 322 Cr. | 136 | 205/71.6 | 28.1 | 38.6 | 0.00 % | 8.34 % | 7.69 % | 10.0 |
| Everest Organics Ltd | 270 Cr. | 278 | 536/197 | 46.2 | 74.7 | 0.00 % | 1.76 % | 2.23 % | 10.0 |
| Gennex Laboratories Ltd | 252 Cr. | 10.4 | 17.2/7.05 | 14.4 | 8.79 | 0.00 % | 13.0 % | 10.2 % | 1.00 |
| Aarey Drugs & Pharmaceuticals Ltd | 250 Cr. | 88.3 | 100/47.8 | 73.0 | 52.5 | 0.00 % | 6.38 % | 2.96 % | 10.0 |
| Nectar Lifescience Ltd | 229 Cr. | 11.8 | 28.3/9.20 | | 32.0 | 0.00 % | 5.36 % | 11.2 % | 1.00 |
| BDH Industries Ltd | 216 Cr. | 375 | 524/241 | 20.7 | 123 | 1.20 % | 17.8 % | 14.2 % | 10.0 |
| Lyka Labs Ltd | 206 Cr. | 57.6 | 129/44.1 | | 28.3 | 0.00 % | 9.91 % | 9.31 % | 10.0 |
| Ambalal Sarabhai Enterprises Ltd | 203 Cr. | 26.5 | 42.0/23.1 | 11.4 | 19.2 | 0.00 % | 9.12 % | 6.25 % | 10.0 |
| Brooks Laboratories Ltd | 199 Cr. | 67.5 | 166/36.3 | 9.21 | 39.3 | 0.00 % | 9.93 % | 12.2 % | 10.0 |
| Auro Laboratories Ltd | 156 Cr. | 250 | 317/159 | 52.8 | 69.9 | 0.00 % | 3.85 % | 4.33 % | 10.0 |
| Coral Laboratories Ltd | 152 Cr. | 427 | 785/360 | 10.7 | 596 | 0.35 % | 17.4 % | 13.1 % | 10.0 |
| Alpa Laboratories Ltd | 144 Cr. | 68.5 | 120/46.0 | 12.2 | 92.0 | 0.00 % | 15.0 % | 11.5 % | 10.0 |
| Lactose (India) Ltd | 142 Cr. | 113 | 137/76.0 | 29.4 | 49.6 | 0.00 % | 12.9 % | 9.69 % | 10.0 |
| Gujarat Inject (Kerala) Ltd | 140 Cr. | 95.5 | 95.9/17.0 | 560 | 6.93 | 0.00 % | 13.5 % | 11.0 % | 10.0 |
| Achyut Healthcare Ltd | 128 Cr. | 5.42 | 6.80/3.18 | 297 | 1.34 | 0.00 % | 2.26 % | 1.77 % | 1.00 |
| Krebs Biochemicals & Industries Ltd | 128 Cr. | 59.3 | 114/38.3 | | 74.6 | 0.00 % | 30.1 % | % | 10.0 |
| Bal Pharma Ltd | 121 Cr. | 76.3 | 113/59.7 | 15.0 | 49.2 | 1.57 % | 10.1 % | 9.66 % | 10.0 |
| Godavari Drugs Ltd | 117 Cr. | 115 | 130/69.7 | 33.4 | 60.3 | 0.00 % | 10.1 % | 10.6 % | 10.0 |
| Par Drugs & Chemicals Ltd | 112 Cr. | 91.1 | 122/78.0 | 8.06 | 86.5 | 0.00 % | 18.4 % | 13.6 % | 10.0 |
| Concord Drugs Ltd | 112 Cr. | 85.0 | 92.5/29.0 | 211 | 26.1 | 0.00 % | 4.73 % | 0.88 % | 10.0 |
| Pharmaids Pharmaceuticals Ltd | 105 Cr. | 29.7 | 73.4/27.1 | | 14.7 | 0.00 % | 17.4 % | 16.3 % | 10.0 |
| Aurobindo Pharma Ltd | 82,114 Cr. | 1,414 | 1,460/1,016 | 23.2 | 603 | 0.28 % | 14.2 % | 11.1 % | 1.00 |
| Mankind Pharma Ltd | 93,605 Cr. | 2,267 | 2,727/1,910 | 53.0 | 376 | 0.04 % | 15.0 % | 13.9 % | 1.00 |
| Cipla Ltd | 1,04,608 Cr. | 1,295 | 1,673/1,166 | 22.0 | 408 | 1.00 % | 22.7 % | 17.8 % | 2.00 |
| Lupin Ltd | 1,04,973 Cr. | 2,296 | 2,381/1,837 | 21.1 | 430 | 0.52 % | 21.3 % | 20.6 % | 2.00 |
| Dr Reddys Laboratories Ltd | 1,09,933 Cr. | 1,317 | 1,380/1,121 | 19.7 | 432 | 0.61 % | 22.7 % | 18.0 % | 1.00 |
| Torrent Pharmaceuticals Ltd | 1,39,345 Cr. | 4,117 | 4,483/3,101 | 60.4 | 250 | 0.78 % | 27.0 % | 26.5 % | 5.00 |
| Sun Pharmaceuticals Industries Ltd | 3,88,788 Cr. | 1,620 | 1,851/1,547 | 32.0 | 324 | 0.99 % | 20.2 % | 16.9 % | 1.00 |
| Chandra Bhagat Pharma Ltd | 24.9 Cr. | 33.0 | 61.5/30.0 | 40.2 | 40.3 | 0.00 % | 6.00 % | 2.41 % | 10.0 |
| Fervent Synergies Ltd | 90.3 Cr. | 18.1 | 29.8/16.0 | 26.2 | 10.8 | 0.00 % | 7.47 % | 7.47 % | 10.0 |
| Biofil Chemicals & Pharmaceuticals Ltd | 54.0 Cr. | 33.2 | 57.2/25.6 | 19.5 | 13.1 | 0.00 % | 4.12 % | 3.03 % | 10.0 |
| Checkpoint Trends Ltd | 28.4 Cr. | 51.8 | 144/16.1 | 13.8 | 3.60 | 0.00 % | 16.5 % | 9.17 % | 10.0 |
| Colinz Laboratories Ltd | 5.91 Cr. | 46.9 | 87.9/36.1 | 12.1 | 39.2 | 0.00 % | 6.72 % | 5.43 % | 10.0 |
| Dipna Pharmachem Ltd | 22.8 Cr. | 8.68 | 26.3/7.45 | 11.1 | 24.5 | 0.00 % | 6.64 % | 2.55 % | 10.0 |
| Ind-Swift Ltd | 85.4 Cr. | 15.8 | 19.9/12.0 | 10.9 | 74.2 | 0.00 % | 11.9 % | % | 2.00 |
| Evoq Remedies Ltd | 9.44 Cr. | 3.79 | 6.11/2.27 | 5.36 | 17.9 | 0.00 % | 0.35 % | 0.26 % | 10.0 |
| Amerise Biosciences Ltd | 4.89 Cr. | 0.74 | 0.93/0.50 | 69.9 | 0.81 | 0.00 % | 0.19 % | 0.19 % | 1.00 |
| Murae Organisor Ltd | 38.8 Cr. | 0.19 | 1.12/0.19 | 2.56 | 1.02 | 0.00 % | 4.20 % | 5.69 % | 1.00 |
| Ganga Pharmaceuticals Ltd | 7.09 Cr. | 12.0 | 14.8/9.35 | 88.6 | 14.0 | 0.00 % | 3.18 % | 1.13 % | 10.0 |
| Bacil Pharma Ltd | 80.4 Cr. | 56.0 | 61.8/26.7 | 109 | 18.4 | 0.00 % | 0.97 % | 0.98 % | 10.0 |
| Adline Chem Lab Ltd | 6.60 Cr. | 11.3 | 19.1/7.60 | 220 | 2.75 | 0.00 % | % | % | 10.0 |
| Beryl Drugs Ltd | 11.0 Cr. | 21.7 | 30.0/15.9 | 1,101 | 18.6 | 0.00 % | 10.2 % | 6.30 % | 10.0 |
| MPS Pharmaa Ltd | 3.31 Cr. | 1.73 | 3.15/1.57 | | 0.33 | 0.00 % | 9.79 % | 59.0 % | 10.0 |
| Gujarat Terce Laboratories Ltd | 29.4 Cr. | 37.8 | 68.4/29.0 | | 10.1 | 0.00 % | 41.4 % | 14.6 % | 10.0 |
| Fabino Enterprises Ltd | 4.06 Cr. | 19.4 | 39.0/13.0 | | 19.2 | 0.00 % | 7.16 % | 3.08 % | 10.0 |
| Decipher Labs Ltd | 7.93 Cr. | 7.85 | 12.5/5.00 | | 19.0 | 0.00 % | 4.67 % | 1.16 % | 10.0 |
| Cian Healthcare Ltd | 20.6 Cr. | 8.26 | 8.26/3.07 | | 13.0 | 0.00 % | 10.6 % | 30.3 % | 10.0 |
| Chemo Pharma Laboratories Ltd | 16.5 Cr. | 110 | 153/75.0 | | 9.60 | 0.00 % | 5.17 % | 3.47 % | 10.0 |
| Brawn Biotech Ltd | 6.89 Cr. | 23.0 | 24.4/15.7 | | 12.3 | 0.00 % | 42.5 % | 41.3 % | 10.0 |
| Bharat Immunological & Biological Corporation Ltd | 76.3 Cr. | 17.7 | 28.8/14.1 | | 18.2 | 0.00 % | 9.27 % | 17.7 % | 10.0 |
| ANG Lifesciences India Ltd | 39.8 Cr. | 30.5 | 39.7/17.6 | | 50.0 | 0.00 % | 3.54 % | 13.8 % | 10.0 |
| Vivimed Labs Ltd | 55.6 Cr. | 6.71 | 29.4/5.15 | | 5.79 | 0.00 % | 8.10 % | % | 2.00 |
| Ortin Laboratories Ltd | 16.4 Cr. | 20.1 | 26.4/16.2 | | 3.47 | 0.00 % | 60.2 % | 118 % | 10.0 |
| Industry Average | 19,737.15 Cr | 1,103.08 | | 59.48 | 201.13 | 0.36% | 16.35% | 15.16% | 6.10 |